On September 30, 2025, from 2:00 – 4:00 PM ET, NIH and the New England Biological Safety Association, the Mid-Atlantic Biological Safety Association, the Chesapeake Area Biological Safety Association, and the Northeast Biological Safety Association will be co-hosting a virtual listening session to obtain input from stakeholders on NIH’s recently announced initiative to modernize and strengthen […] The post NIH and its Partners to Co-Host Regional Listening Session on Efforts to Moderni...| Office of Science Policy
On September 29, 2025, from 1-3 PM ET, NIH will be hosting a virtual meeting of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC). At this meeting, the committee will discuss the draft report of the Engaging the Public as Partners in Clinical Research (ENGAGE) Working Group. A draft agenda, meeting materials, and webcast information […] The post Upcoming Meeting of the Novel and Exceptional Technology and Research Advisory Committee appeared first on O...| Office of Science Policy
Today, NIH announced a new effort to modernize and strengthen biosafety policies, practices, and oversight. This forward-looking effort aims to ensure that NIH’s biosafety framework keeps pace with evolving risks posed by rapid advances in science and technology. NIH is committed to building a 21st century biosafety system that reflects the realities of today’s scientific […] The post NIH Launches Comprehensive Effort to Modernize Biosafety Framework appeared first on Office ...| Office of Science Policy
On July 30, 2025, NIH released a proposal to maximize research funds by limiting allowable publication costs. As a reminder, comments on the proposal will be accepted until September 15, 2025, via NIH’s comment portal. Additionally, to support maximal transparency and foster open science, NIH has published the underlying datasets to accompany the detailed description of the methodology […]| Office of Science Policy
Today, NIH released its implementation plan for driving gold standard science. NIH’s Gold Standard Science Implementation Plan outlines our key accomplishments to date and presents a transparent vision for the road ahead. To learn more and to access the plan, please see the statement issued today by NIH Director, Dr. Jay Bhattacharya. Questions may be sent to SciencePolicy@od.nih.gov. […]| Office of Science Policy
To maximize the value of NIH research grants, grantees should aim to utilize as much of their funds as possible for research activities. With this in mind, NIH has released a request for information (RFI) regarding policy options to maximize research funds by limiting allowable publication costs (APCs). Stakeholders are invited to provide feedback on […] The post NIH Releases Request for Information on Maximizing Research Funds by Limiting Allowable Publication Costs appeared fi...| Office of Science Policy
You may have recently heard the NIH Director speak about the importance of academic freedom in scientific discovery. In short, NIH defines academic freedom as the ability to engage in open, rigorous discourse to stress test ideas, challenge the status quo, and shape the most impactful path forward. Now, I might be biased – but […]| Office of Science Policy
The use of Artificial Intelligence (AI) tools can be helpful in limited aspects of preparing NIH research applications. However, it is critical to maintain the fairness and originality of NIH’s research application process. The rapid submission of large numbers of research applications from a single Principal Investigator (PI) may also unfairly strain NIH’s application review […] The post NIH Issues Policy to Support Originality and Fairness in Research Application Process appeared fi...| Office of Science Policy
Effective today, the NIH Public Access Policy is in effect and manuscripts accepted for publication in a journal on or after July 1, 2025, must be submitted to PubMed Central for public availability without embargo upon the official date of publication. To assist with compliance, NIH has developed a new website dedicated to the Public […]| Office of Science Policy
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have published a new glossary of clinical research terms related to innovative clinical trial design, including studies using real-world data to generate real-world evidence. This glossary is intended to facilitate communication within the clinical research community by establishing a common vocabulary. […]| Office of Science Policy